Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by 90guppyon Dec 03, 2020 4:29pm
107 Views
Post# 32031159

RE:RE:RE:Today's update was interesting, why

RE:RE:RE:Today's update was interesting, whytwo tests going at the same time. The USA is an advance preclinical using the genetically engineered mice,while the oral test is in the Israel and ready to moved to phase 1, since it is already human application and its In Vivo test using Tel Aviv Hospital mice is already proven.Two govts will vie for partnership with VXL, USA versus Israel.

bigbanktheory wrote:
90guppy wrote: Bingo, bigbank, looks like there are two targets now for VXL. The US govt and Israel, it seems the clinical trial is gonna move as well in Israel, including this oral route


bigbanktheory wrote: Why would Vxl even mention taking it orally if they know their results are negative?

 


Hey 90Guppy. I hope all is good. For me, the ace up the sleeve is the patent. If we get that soon, it could blend into the equation with perfect timing. But I have no idea. What are your thoughts?


<< Previous
Bullboard Posts
Next >>